IRLAB Therapeutics AB
IRLAB A SE0012675361
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
5% | -12% | -81% | 22% | -3% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Kristina Torfgård CEO |
15.75 SEK |
4,500 Bought |
70,875 SEK |
05/08/2024 | 05/08/2024 |
Kristina Torfgård CEO |
15.65 SEK |
9,000 Bought |
140,850 SEK |
05/08/2024 | 05/08/2024 |
Veronica Wallin DIR |
15.90 SEK |
5,000 Bought |
79,500 SEK |
28/05/2024 | 28/05/2024 |
Carola Elisabet Lemne CB |
15.55 SEK |
4,000 Bought |
62,200 SEK |
21/05/2024 | 21/05/2024 |
Catharina Gustafsson Wallich DIR |
15.30 SEK |
8,000 Bought |
122,400 SEK |
30/05/2024 | 21/05/2024 |
Gunnar Olof Olsson CEO |
15.50 SEK |
2,000 Bought |
31,000 SEK |
14/05/2024 | 14/05/2024 |
Viktor Siewertz CFO |
13.61 SEK |
5,000 Bought |
68,037 SEK |
13/05/2024 | 13/05/2024 |
Daniel Johnsson DIR |
12.98 SEK |
20,000 Bought |
259,680 SEK |
10/05/2024 | 10/05/2024 |
Joakim Tedroff O |
39.64 SEK |
51,430 Bought |
2,038,685 SEK |
05/04/2023 | 03/04/2023 |
Richard Godfrey CEO |
34.89 SEK |
5,000 Bought |
174,457 SEK |
05/09/2022 | 01/09/2022 |